Adverse events associated with oral small-molecule drugs in the treatment of psoriasis and psoriatic arthritis: a pharmacovigilance study based on the FAERS database
This data is the supplementary data for a manuscript entitled "Adverse events associated with oral small-molecule drugs in the treatment of psoriasis and psoriatic arthritis: a pharmacovigilance study based on the FAERS database. In our study, we revealed the distinct adverse event (AE) profile...
Gespeichert in:
1. Verfasser: | |
---|---|
Format: | Dataset |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | This data is the supplementary data for a manuscript entitled "Adverse events associated with oral small-molecule drugs in the treatment of psoriasis and psoriatic arthritis: a pharmacovigilance study based on the FAERS database. In our study, we revealed the distinct adverse event (AE) profiles of two marketed oral small-molecule drugs, namely apremilast and deucravacitinib. |
---|---|
DOI: | 10.17632/p7g3bspg6x |